We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.33 | 3.70% | 9.25 | 9.00 | 9.50 | 9.30 | 9.25 | 9.30 | 180,216 | 09:12:40 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.17 | 85.82M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/10/2017 13:17 | In November Scancell are attending : PEGS - & Health EX World Forum - but also November sees the publication of Moditope related news - via the EPO which fingers crossed should see news of some consequence. Scope then perhaps for an announcement or two in the not too distant future. | gooosed | |
19/10/2017 10:37 | Talk about drama!!! | chelsea35 | |
19/10/2017 09:21 | ONW.. precisely, and as we get closer to that " deadline " ( because thats what it will be seen as by the market )the more pressure will be applied to the SP, which in turn then damages any unmet funding requirements... its a catch 22. Hence why, for the first time, 2018 will indeed be a " pivotal year ". This time next year we will either be sitting quite nicely with 2 funded trials in place, and hopefully some cash in the bank, or, the family jewels will have been sold in a fire sale. The company were clearly pinning their hopes on finance being available from the US, but YET AGAIN, RG failed to deliver. One hopes that his bullish statement at this years AGM is, for the first time, backed up with form of substance. Every other year, he has made all the right noises, but brought absolutely zero to the table. But as you say, lets wait and see what happens over the next 2 - 3 months. | tosh123 | |
19/10/2017 08:46 | C7 Actually the last year was about cash raising (remember the 2016 JC AGM comment next year Scancell will be a "different company"?) But in 2017 AGM JC mentioned the drive for US funds was not sucessful, and we've been told to go back and try again IDC. Sadly the Company remained the same. By definition the development of both platforms continued and good (if not great) progress has been made.... BUT however we look at it the US Funding didn't happen. So I think the latest situation (Will RG bequeath his successor a cash pile to spend by early next year?) is the one upon which the market will focus... As I've stated before, I remain hopeful of success in that... Just have to wait and see. AIMO ATB | oldnotwise | |
19/10/2017 07:09 | Yes it has, but the last year was about clinical development and having the SCIB1 vaccine manufactured. An enormous amount has been tested with Moditope , Auotogaphry and citrulisation, so we are probably in a much better place now to increase our chances of successful trials and having both platforms packaged. Not selling now or trading it. Agema funding is not overdue, just your opinion which i disagree with. The £5m has paid the years losses with change. I would argue we are better positioned now than last year. | chelsea35 | |
19/10/2017 06:33 | Chelsea No. A deal has been sought for several years. A partner or a buyout or major investor. The fact that funding is overdue and the programme has fallen behind schedule all leads to the fact that any funding has been harder to find and not entirely as Scancell wanted. As I posted. But I agree with such a short timespan now put on matters, it looks like something is forthcoming. But will it be enough.? Also at what price and dilution or equity will it cost Scancell.? For certain matters have not gone entirely scancells own way. As I have always said. Coin in the air time. | agema | |
19/10/2017 05:35 | C7, heard it all before "more jam tomorrow " I can only judge the Companies and RG's deal making on past efforts which imo have been shocking, considering the "trade deal" in 2013/14 was negated, this surely should of gave RG ammunition for financing at a premium. Imo it tells me the deal was not the " many multiples" RG had talked about. Time is now of the essence as imo the stock market bubble is about to burst especially in the US where P/E ratios are seriously over balanced at between 2 to 3 times what they should be. AIMO | wanderer1210_0 | |
19/10/2017 05:09 | Agema, morning. Well thats your opinion. We don"t know if that is the case at all, but we do know deals take time.RG has put quite short timelines on it. He certainly laid out in some detail our plans with loads of confidence. We await, and there is a lot of news to come from here on now. | chelsea35 | |
19/10/2017 04:20 | Chelsea It’s not just getting a deal. It’s also the terms of that deal. Given how long it is taking, I would guess that any potential deal out there is not as favourable to Scancell as they would have wanted or liked. | agema | |
19/10/2017 02:10 | smiler, that is true, but given the timelines and hopes now who would want too?? | chelsea35 | |
18/10/2017 18:00 | "Enlightening.Bottom line - nigh on everyone continues to hold."Nigh on everyone can't afford to sell. | wanderer1210_0 | |
18/10/2017 11:26 | don't worry, no one reads any of this hehe! :-) | oldnotwise | |
18/10/2017 11:12 | Or to know even. | 10acious | |
18/10/2017 11:10 | ONWMe too really but I don't want everyone know! | 10acious | |
18/10/2017 10:34 | Buying too. | chelsea35 | |
18/10/2017 10:33 | My interpretation of the recent posts is that if a deal is struck then the shares will probably go up, and if it is not struck then the shares will probably go down.Enlightening.Bo | wigwammer | |
18/10/2017 10:01 | 10acious 1275 ref your PS I am LOL ATB | oldnotwise | |
18/10/2017 09:59 | BoB your 12074 Thanks for the response.... great to be able to amicably agree to disagree.... :-) Those exchanges make it worthwhile posting in my view! ATB | oldnotwise | |
18/10/2017 09:55 | Bermudashorts your 12067It certainly can, I am a glass half full type of guy ( preferably full ) but in the case of investing as you know, you have to be able to stand back and dispassionately interpret the data..separate the definitive from the fudge! If your not sure, it's fudge, if it's subject to interpretation,it's fudge.With Scancell there's too much fudge which is fine for a speculative punt but dangerous for an investment.Someone is going to say...but Legal and General are board now!A tiny speculative punt in their huge investment ocean that if it sinks will go completely unnoticed as indeed it will if it succeeds.That and the fact that it's not really their money but a little bit of a million or so people's pensions investment.PS I am not really a cynic. | 10acious | |
18/10/2017 09:27 | ONW - thanks for your reasoned explanation. We could continue to debate all day. For every investor who sees RG's departure as a deadline, there'll be another willing to give the new CEO a chance. Time will tell. It's a pointless debate really, we both agree that there is an event on the horizon, but differ on which one and when. Think we know each other well enough and are comfortable enough with our positions to agree to disagree. | bermudashorts | |
18/10/2017 09:05 | BoB I take your point... but I must take issue with your conclusion. The market is made up of many types (and please believe me I'm not trying to teach grandma to suck eggs :-))and some of those types will take/have taken the RG comment of the maturity of implied deal (within a specific timeframe - New CEO's appointment ...Jan 2018)as a challenge/tipping point/milestone (call it what you will)and on the premise of "buy the rumour sell the fact" IMO RG has set the share price up once again. This is not a criticism if the deal is forthcoming in the timeframe in which he couched it (and there was a great deal of talk about not being able to say anything etc)....In fact a worthwhile deal will "do the trick" for the share price on several fronts.... and that's why I've personally decided to back the BOD by retaining my holding.... BUT failure to provide the implied panacea for the company's fortunes will IMO create a problem for the share price By embarking on the course of action regarding a capital provision for the new CEO I believe the market has a target to focus on and there'll be many who don't give a hoot about the company who want to take the gamble on the "good times" being announced sometime between now and 10th January and the subsequent share price "recovery" talk of which we all know and love. In my view for anyone who takes the view that RG was not making any statement about a forthcoming "deal" there'll be at least one who believes he was, and in those circumstances failure to deliver the implied deal (or deal announcement) will not bode well for the share price I'll not even consider that he meant a new equity investor might be on the cards.. That's a completely different matter... although oddly it could be a good thing! This is all in my opinion, and I know it will upset many, but that's the way I see it, maybe I'm too cynical and I really do hope that RG "pulls it off"! :-) I just wanted to defend my position by setting out the stall on which I put my investmentdecision ie HOLD! Again, hope this makes sense and in no way am I criticising anyone or anything, just saying why I've made the comments I have. AIMO ATB | oldnotwise | |
18/10/2017 09:02 | Tosh, and don't forget RG stated 2 years ago " Funding is easy for a Company with a successful Phase 11 behind it ". | panama7 | |
18/10/2017 08:47 | B... the change in leadership and the funding deadline are one and the same... I dont give a flying one about RG's departure( it should have happened a long long time ago ) but what i do care about, is FUNDING, and whether you like it or not RG made a specific statement and therein confirmed a timeline. If this timeline is missed, then all bets are off. | tosh123 | |
18/10/2017 08:44 | Bermuda. The way I read it is, Scancell aim to do a deal to cause the share price to rise off the back of which they will be in a better place to go and secure funding? But does this mean the deal they are aiming for comes with no cash / up front payments etc? | rhatton | |
18/10/2017 08:38 | Tosh, You underestimate the intelligence of those attending the AGM and also those reading your comments. RG was clear that he hoped to complete a deal by the time he handed over to CH but by no means gave any guarantees. There is no finite target date on which any ongoing negotiations or due diligence suddenly stop simply because the CEO has changed to a non-exec role. The make or break event here is not the change in leadership, it's if the Company come back to the market for funding. Then we will know that there is no deal on the table. So I stand by my comments that nothing has changed. | bermudashorts |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions